Quick Answer
TELA Bio, Inc. reported Total Assets of $81.42 million for fiscal year 2025.
TELA Bio, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $81.42M | -6.0% |
| 2024 | $86.57M | +10.9% |
| 2023 | $78.05M | +15.0% |
| 2022 | $67.86M | +8.5% |
| 2021 | $62.54M | -27.7% |
| 2020 | $86.46M | +27.3% |
| 2019 | $67.92M | +149.5% |
| 2018 | $27.23M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $61.59M | +16.2% | -8.8% |
| June 30, 2025 | $67.54M | +12.2% | -12.6% |
| March 31, 2025 | $77.25M | +7.5% | -10.8% |
| December 31, 2024 | $86.57M | +10.9% | +63.3% |
| September 30, 2024 | $53.02M | -39.3% | -11.9% |
| June 30, 2024 | $60.20M | -36.2% | -16.2% |
| March 31, 2024 | $71.84M | +22.2% | -8.0% |
| December 31, 2023 | $78.05M | +15.0% | -10.6% |
- TELA Bio, Inc. showed a decrease of -6.0% in Total Assets compared to the prior fiscal year.
- Over the 2018–2025 period, TELA Bio, Inc.’s total assets has grown by 199.0% (from $27.23 million to $81.42 million).
- The most recent figure is from TELA Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: